How a biologic asthma treatment works in everyday clinical practice

This is a one-year study that follows adults with severe eosinophilic asthma who are already receiving benralizumab, a biologic medication that helps reduce certain immune cells involved in asthma. Researchers want to understand how well this medication works in everyday clinical practice—not in a controlled lab setting—by tracking your asthma control, quality of life, and medication use over time.

Benralizumab is approved to treat severe eosinophilic asthma, but researchers want to learn more about how it performs when patients use it in their normal lives, outside of clinical trials. This real-world information helps doctors better understand whether and how the medication improves asthma control and helps patients reduce other asthma medications.